Literature DB >> 10864081

Transient radiographic progression during initial treatment of pulmonary tuberculosis: CT findings.

M Akira1, M Sakatani, H Ishikawa.   

Abstract

PURPOSE: A study was undertaken to describe the thin-section CT features of transient radiographic progression during initial treatment of active pulmonary tuberculosis.
METHOD: The CT scans of 13 patients who developed transient radiographic progression during initial treatment of pulmonary tuberculosis were evaluated and compared with those of 10 patients with true progression of pulmonary tuberculosis. Two patients underwent transbronchial lung biopsy for pathologic evaluation of new lesion.
RESULTS: Eight patients had increased opacity at the site of their original lesion, whereas five had new opacities elsewhere: ipsilateral (n = 3) or contralateral (n = 1) to the original lesion or both (n = 1). Relatively extensive areas of ground-glass attenuation were concomitantly depicted in three of the eight patients with progression in the area of the original lesion. In those with progression ipsilateral or contralateral to the lesion, the character of the new lesions was ground-glass opacity and/or consolidation mainly in the subpleural region. Transbronchial lung biopsy specimens obtained from two patients showed intraluminal organizing exudates and thickened alveolar septa with lymphocyte infiltration, whereas the dominant CT findings of true progression of pulmonary tuberculosis were nodules (n = 8) or centrilobular nodules (n = 7).
CONCLUSION: Thin-section CT may be useful to differentiate transient radiographic progression from true progression of pulmonary tuberculosis.

Entities:  

Mesh:

Year:  2000        PMID: 10864081     DOI: 10.1097/00004728-200005000-00014

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

Review 1.  Multi-drug resistant childhood tuberculosis.

Authors:  Varinder Singh; Satnam Kaur
Journal:  Indian J Pediatr       Date:  2010-12-31       Impact factor: 1.967

2.  Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.

Authors:  Kristin N Adams; Kevin Takaki; Lynn E Connolly; Heather Wiedenhoft; Kathryn Winglee; Olivier Humbert; Paul H Edelstein; Christine L Cosma; Lalita Ramakrishnan
Journal:  Cell       Date:  2011-03-03       Impact factor: 41.582

Review 3.  Revisiting the role of the granuloma in tuberculosis.

Authors:  Lalita Ramakrishnan
Journal:  Nat Rev Immunol       Date:  2012-04-20       Impact factor: 53.106

4.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

5.  Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis.

Authors:  Richa Mishra; Sakshi Kohli; Nitish Malhotra; Parijat Bandyopadhyay; Mansi Mehta; MohamedHusen Munshi; Vasista Adiga; Vijay Kamal Ahuja; Radha K Shandil; Raju S Rajmani; Aswin Sai Narain Seshasayee; Amit Singh
Journal:  Sci Transl Med       Date:  2019-11-13       Impact factor: 17.956

6.  Paradoxical Reaction In The Form Of New Pulmonary Mass During Anti-Tuberculosis Treatment: A Case Series And Literature Review.

Authors:  Ting Guo; Wei Guo; Min Song; Shanshan Ni; Man Luo; Ping Chen; Hong Peng
Journal:  Infect Drug Resist       Date:  2019-11-26       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.